16.800
+0,00%
2026-10-16
Fundamental Analysis
89 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +79.9% | +65.6% | 3 / 3 | +16.2% | +6.70 pp | +5.03 pp | +19.8% | 0.01 | 6.72 | 60,3 | +16,2% | 8,6 | +79,9% | 6.72 | 8.14 | −17,5% |
| Pts | 12 | 12 | 12 | 8 | 12 | 12 | 8 | 12 | 8 | |||||||
Valuation annotation:Price: 16.800 (close price on 2026-10-16)EPS (TTM): 2.501
Financial charts
1.Revenue & growth
VND bn60,3Q2/26
1.Revenue & growth
VND bn60,3Q2/26
2.Profit & growth
VND bn8,57Q2/26
3.Profit mix (Penman)
VND bn28,6Q2/26
4.Margins & cost structure
%34.2%Q2/26
5.Returns & cash cycle
% · days20.7%Q2/26
6.Earnings quality & cash
VND bn25,1Q2/26
7.Asset structure
VND bn139Q2/26
8.Funding & debt health
VND bn · times139Q2/26
9.Revenue backlog
VND bn0,63Q2/26
10.Valuation
times · %6,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %948Q2/26
Adjusted EPS growth, latest quarter
79.9%
Average adjusted EPS growth, 3 quarters
65.6%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26